Regeneron rallies after earnings
Regeneron stock: +16.3% after earnings, first price target already hit
Regeneron rallies after earnings
Our view last week
Regeneron slipped 3.1% this week, yet held the same base as last week: a clean double bottom in the 599 area, with a 4% intermediate rebound confirming its strength. Regeneron stock stays inside the buy signal, now in its second week, while the ADX keeps sliding and buyers lose steam. In the background, this week's technical analysis also has earnings due, right around the corner.
This week's summary
Regeneron stock closes the week with a 16.3% surge, the rebound last week's double bottom in the 599 area seemed to promise. Buyers dominate almost every trade, 94.7% of volume, and the daily RSI climbs to 78, deep in overbought territory. The buy signal, now in its third week, holds: the trade is up 14.8% since entry.
IQS Phase
54
ordinary
Signal Strength
59
medium
Sizing
STANDARD
Ranking
#40 / 120
US stocks in progress
Trade P&L %
+14.76%
from signal to date, no stop loss
Rank position
ranks 40th among the 120 Longs already running for US stocks in our ranking, with a signal strength of 59 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
REGN belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content